| Literature DB >> 28890505 |
Akihiro Ito1, Tadashi Ishida1, Hiromasa Tachibana2, Yuhei Ito1, Takuya Takaiwa3, Hiroyuki Fujii4, Toru Hashimoto4, Hiroshi Nakajima5, Junko Amemura-Maekawa6.
Abstract
Legionella species are important causative pathogens for severe community-acquired pneumonia (CAP). Most cases of Legionella pneumonia are due to Legionella pneumophila serogroup 1, and CAP due to L. pneumophila serogroup 9 is rare. A fourth case of CAP due to L. pneumophila serogroup 9 has been reported, and initial treatment using single-dose oral azithromycin appeared useful. Azithromycin or fluoroquinolone injection is usually recommended for the treatment of Legionella pneumonia, and no previous reports have shown the effectiveness of single-dose oral azithromycin. This case report is therefore valuable from the perspective of possible treatment for mild to moderate Legionella pneumonia using single-dose oral azithromycin.Entities:
Keywords: Legionella pneumophila serogroup 9; community-acquired pneumonia (CAP); initial treatment; single-dose oral azithromycin
Mesh:
Substances:
Year: 2017 PMID: 28890505 DOI: 10.7883/yoken.JJID.2016.548
Source DB: PubMed Journal: Jpn J Infect Dis ISSN: 1344-6304 Impact factor: 1.362